SBRNA
Live / Allowed — Fourth extension granted (statement of use) (as of 06 May 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 08 Dec 2022 filing date already counts against anyone who files later.
Record
- Serial number
- 97709367
- Mark type
- Word mark
- Filed
- 08 Dec 2022
- Published for opposition
- 12 Mar 2024
- Attorney of record
- Syed Abedi
Goods and services
- Class 001 — Chemicals: Clinical preparations in the nature of chemicals and biochemicals for use in the manufacture of medical preparations for treatment of genetic diseases
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of genetic diseases; pharmaceutical preparations, namely, RNA therapeutics for use in the treatment of genetic diseases
- Class 042 — Scientific and technological services: Development of pharmaceutical preparations and medicines for genetic diseases; testing, inspection, research, and development of pharmaceutical preparations for genetic diseases
Owner
- Iris Medicine, Inc., Berkeley, CA, US
- Iris Medicine, Inc., Berkeley, CA, US
Prosecution history
- 07 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 May 2026 — SOU EXTENSION 4 GRANTED
- 06 May 2026 — SOU EXTENSION 4 FILED
- 06 May 2026 — SOU TEAS EXTENSION RECEIVED
- 08 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Nov 2025 — SOU EXTENSION 3 GRANTED
- 07 Nov 2025 — SOU EXTENSION 3 FILED
- 07 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 30 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Apr 2025 — SOU EXTENSION 2 GRANTED
- 29 Apr 2025 — SOU EXTENSION 2 FILED
- 29 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 06 Nov 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Nov 2024 — SOU EXTENSION 1 GRANTED
- 06 Nov 2024 — SOU EXTENSION 1 FILED